Every 10-Q that Quaker Houghton (KWR) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow KWR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full KWR filings page.
Quaker Chemical Corporation delivered improved results for the quarter ended June 30, 2026. Net sales were $532.6 million, up 10% from a year earlier, driven by roughly 7% higher volumes, 2% favorable currency and 1% price/mix. Net income was $26.8 million versus a prior-year loss of $66.6 million, with diluted EPS of $1.55.
Excluding non-recurring and non-core items, non-GAAP net income was $37.9 million ($2.19 per diluted share), and adjusted EBITDA was $85.2 million, up from $75.5 million. All three segments grew sales; EMEA and Asia/Pacific increased operating earnings on better margins, while Americas earnings declined on lower margins and higher SG&A despite higher revenue.
Operating cash flow for the first half of 2026 was $33.2 million, as higher earnings were offset by working-capital outflows from higher receivables and inventory builds amid supply-chain risks. The company ended the quarter with $155.1 million of cash and $876.1 million of debt and remained in compliance with its Amended Credit Facility covenants.
Management continued multi-year restructuring, including a 2026 global transformation program and the 2022 cost and optimization program, together reducing headcount by about 540 positions and leaving $8.8 million accrued. An immaterial cash-flow presentation error in revolving credit activity was identified and will be revised in future comparative periods.
Quaker Chemical Corporation reported higher results for the first quarter of 2026, with net sales of $480.5 million, up 8% from $442.9 million a year earlier. Growth came from roughly 3% higher organic volumes, about 4% from acquisitions, and a 4% favorable currency impact, partly offset by a 3% decline in selling price and product mix.
Net income rose to $19.7 million, or $1.13 diluted EPS, from $12.9 million, or $0.73, while non-GAAP net income was $28.4 million and non-GAAP diluted EPS was $1.63 versus $28.0 million and $1.58. Adjusted EBITDA increased to $72.5 million from $69.0 million as gross margin improved to 36.8%. Operating cash flow turned positive at $3.8 million versus a $3.1 million outflow, and cash ended at $169.7 million against total borrowings of $875.0 million. The company launched a 2026 global business transformation program targeting at least $20–$30 million of annualized cost savings, while continuing its 2022 cost program, and noted that Middle East geopolitical tensions have not yet had a material financial impact but pose ongoing supply chain and cost risks.
Quaker Chemical (KWR) reported higher quarterly sales but lower earnings. Q3 2025 net sales were $493.8 million, up from $462.3 million a year ago, driven by broad growth across Americas, EMEA and Asia/Pacific. Operating income was $46.6 million versus $51.7 million, and net income was $30.5 million with diluted EPS of $1.75, down from $1.81.
For the nine months, the company recorded a net loss of $23.2 million, primarily reflecting an $88.8 million non-cash goodwill impairment in EMEA recognized in Q2. Year-to-date restructuring and related charges were $31.1 million. Cash from operations was $89.9 million, while investing cash outflows of $193.0 million reflect acquisitions, notably Dipsol.
The April 2025 Dipsol acquisition totaled $185.6 million and contributed $20.6 million of sales in Q3 and $41.5 million year-to-date. To fund deals, debt increased: total debt was $875.2 million as of September 30, 2025, including $224.1 million drawn on the revolver. Quaker ended Q3 with $172.0 million in cash, declared a quarterly dividend of $0.508 per share, and continued share repurchases. Accumulated other comprehensive loss improved, aided by currency translation gains.